-+ 0.00%
-+ 0.00%
-+ 0.00%

SRX Global Acquires Stake In Vistagen Therapeutics; Deal Terms Were Undisclosed

Benzinga·08/04/2026 09:20:47
語音播報

The Company views Vistagen shares as undervalued and welcomes constructive engagement with its leadership team and Board of Directors to discuss ideas on how to unlock shareholder value.